Lung Nodule Characterization by Artificial Intelligence Techniques
NCT ID: NCT03843164
Last Updated: 2019-04-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
50 participants
OBSERVATIONAL
2019-03-12
2021-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The primary purpose is to evaluate the performances of a novel tool based on radiomics to characterize incidental lung nodules, discovered on computed tomography.
The secondary objectives are:
* to evaluate the variation in the performances of the software based on various technical aspects of the CT, such as radiation dose, reconstruction algorithm, type of scanner,…
* to compare the performances of this software to those of expert readers,
* to analyze the potential impact of this software on patient's management.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Thoracoscopic Localization of Pulmonary Nodules Using Direct Intracavitary Thoracoscopic Ultrasound
NCT01201824
Intra-op vs Pre-op Transbronchial Localization for Small Lung Nodule
NCT03793387
Evaluation of the Effectiveness of Predicting the Integrity of Interlobar Fissures Based on Chest Image AI Technology
NCT05774730
Performance of Lung MRI Combined to Synthetic CT in the Follow-up of Lung Nodules
NCT06825078
Bronchial Ultrasonography Via a Fibrescope: Pilot Study in Tumoral Disease
NCT00241267
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
RETROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* With a chest CT acquired between Jan 1 2012 and Oct 1 2018 at the Strasbourg University Hospital;
* CT being available over the PACS and exhibiting at least one lung nodule;
* Patient having given its authorization for the exploitation of his medical data for this research.
Exclusion Criteria
* Patient under juridical protection;
* Patient under tutelage or guardianship.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Strasbourg, France
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Service de Radiologie B - NHC
Strasbourg, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
7311
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.